Article Text
PostScript
Letter
Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis
Statistics from Altmetric.com
Footnotes
Contributors All authors contributed to this manuscript and meet the criteria for authorship.
Funding This research was supported by the Intramural Research Programs of the National Institute of Neurological Disorders and Stroke and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Competing interests PRW has a cooperative research and development agreement with Matinas BioPharma regarding an oral amphotericin formulation.
Patient consent Obtained.
Ethics approval NIH Institutional Review Board.
Provenance and peer review Not commissioned; externally peer reviewed.